FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080202443> ?p ?o ?g. }

• W2080202443 endingPage "17566" @default.
• W2080202443 startingPage "17561" @default.
• W2080202443 abstract "The recent approval of a prostate cancer vaccine has renewed hope for anticancer immunotherapies. However, the immunosuppressive tumor microenvironment may limit the effectiveness of current immunotherapies. Antiangiogenic agents have the potential to modulate the tumor microenvironment and improve immunotherapy, but they often are used at high doses in the clinic to prune tumor vessels and paradoxically may compromise various therapies. Here, we demonstrate that targeting tumor vasculature with lower vascular-normalizing doses, but not high antivascular/antiangiogenic doses, of an anti-VEGF receptor 2 (VEGFR2) antibody results in a more homogeneous distribution of functional tumor vessels. Furthermore, lower doses are superior to the high doses in polarizing tumor-associated macrophages from an immune inhibitory M2-like phenotype toward an immune stimulatory M1-like phenotype and in facilitating CD4 + and CD8 + T-cell tumor infiltration. Based on this mechanism, scheduling lower-dose anti-VEGFR2 therapy with T-cell activation induced by a whole cancer cell vaccine therapy enhanced anticancer efficacy in a CD8 + T-cell–dependent manner in both immune-tolerant and immunogenic murine breast cancer models. These findings indicate that vascular-normalizing lower doses of anti-VEGFR2 antibody can reprogram the tumor microenvironment away from immunosuppression toward potentiation of cancer vaccine therapies. Given that the combinations of high doses of bevacizumab with chemotherapy have not improved overall survival of breast cancer patients, our study suggests a strategy to use antiangiogenic agents in breast cancer more effectively with active immunotherapy and potentially other anticancer therapies." @default.
• W2080202443 created "2016-06-24" @default.
• W2080202443 creator A5015585176 @default.
• W2080202443 creator A5017936529 @default.
• W2080202443 creator A5021963513 @default.
• W2080202443 creator A5022702941 @default.
• W2080202443 creator A5035082371 @default.
• W2080202443 creator A5048844031 @default.
• W2080202443 creator A5051870010 @default.
• W2080202443 creator A5052192469 @default.
• W2080202443 creator A5054359239 @default.
• W2080202443 creator A5058310698 @default.
• W2080202443 creator A5059200813 @default.
• W2080202443 creator A5062284019 @default.
• W2080202443 creator A5066059486 @default.
• W2080202443 creator A5067083694 @default.
• W2080202443 creator A5075652485 @default.
• W2080202443 creator A5089078591 @default.
• W2080202443 creator A5090554105 @default.
• W2080202443 date "2012-10-08" @default.
• W2080202443 modified "2023-10-17" @default.
• W2080202443 title "Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy" @default.
• W2080202443 cites W1560732535 @default.
• W2080202443 cites W1881296535 @default.
• W2080202443 cites W1972111686 @default.
• W2080202443 cites W1988337605 @default.
• W2080202443 cites W1992112921 @default.
• W2080202443 cites W1993519783 @default.
• W2080202443 cites W2000884139 @default.
• W2080202443 cites W2006202974 @default.
• W2080202443 cites W2006833192 @default.
• W2080202443 cites W2021175628 @default.
• W2080202443 cites W2028437938 @default.
• W2080202443 cites W2046905172 @default.
• W2080202443 cites W2057445229 @default.
• W2080202443 cites W2059453983 @default.
• W2080202443 cites W2061123122 @default.
• W2080202443 cites W2061358741 @default.
• W2080202443 cites W2070636596 @default.
• W2080202443 cites W2089258206 @default.
• W2080202443 cites W2096825083 @default.
• W2080202443 cites W2103018035 @default.
• W2080202443 cites W2103563357 @default.
• W2080202443 cites W2109424201 @default.
• W2080202443 cites W2120161817 @default.
• W2080202443 cites W2122930661 @default.
• W2080202443 cites W2126163864 @default.
• W2080202443 cites W2126275851 @default.
• W2080202443 cites W2128565827 @default.
• W2080202443 cites W2134431790 @default.
• W2080202443 cites W2145835533 @default.
• W2080202443 cites W2157769714 @default.
• W2080202443 cites W2158642531 @default.
• W2080202443 cites W2160117150 @default.
• W2080202443 cites W2163035374 @default.
• W2080202443 cites W2165608627 @default.
• W2080202443 cites W2167224460 @default.
• W2080202443 doi "https://doi.org/10.1073/pnas.1215397109" @default.
• W2080202443 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3491458" @default.
• W2080202443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23045683" @default.
• W2080202443 hasPublicationYear "2012" @default.
• W2080202443 type Work @default.
• W2080202443 sameAs 2080202443 @default.
• W2080202443 citedByCount "750" @default.
• W2080202443 countsByYear W20802024432012 @default.
• W2080202443 countsByYear W20802024432013 @default.
• W2080202443 countsByYear W20802024432014 @default.
• W2080202443 countsByYear W20802024432015 @default.
• W2080202443 countsByYear W20802024432016 @default.
• W2080202443 countsByYear W20802024432017 @default.
• W2080202443 countsByYear W20802024432018 @default.
• W2080202443 countsByYear W20802024432019 @default.
• W2080202443 countsByYear W20802024432020 @default.
• W2080202443 countsByYear W20802024432021 @default.
• W2080202443 countsByYear W20802024432022 @default.
• W2080202443 countsByYear W20802024432023 @default.
• W2080202443 crossrefType "journal-article" @default.
• W2080202443 hasAuthorship W2080202443A5015585176 @default.
• W2080202443 hasAuthorship W2080202443A5017936529 @default.
• W2080202443 hasAuthorship W2080202443A5021963513 @default.
• W2080202443 hasAuthorship W2080202443A5022702941 @default.
• W2080202443 hasAuthorship W2080202443A5035082371 @default.
• W2080202443 hasAuthorship W2080202443A5048844031 @default.
• W2080202443 hasAuthorship W2080202443A5051870010 @default.
• W2080202443 hasAuthorship W2080202443A5052192469 @default.
• W2080202443 hasAuthorship W2080202443A5054359239 @default.
• W2080202443 hasAuthorship W2080202443A5058310698 @default.
• W2080202443 hasAuthorship W2080202443A5059200813 @default.
• W2080202443 hasAuthorship W2080202443A5062284019 @default.
• W2080202443 hasAuthorship W2080202443A5066059486 @default.
• W2080202443 hasAuthorship W2080202443A5067083694 @default.
• W2080202443 hasAuthorship W2080202443A5075652485 @default.
• W2080202443 hasAuthorship W2080202443A5089078591 @default.
• W2080202443 hasAuthorship W2080202443A5090554105 @default.
• W2080202443 hasBestOaLocation W20802024431 @default.
• W2080202443 hasConcept C121608353 @default.
• W2080202443 hasConcept C126322002 @default.
• W2080202443 hasConcept C154317977 @default.

• next